ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis.
Saved in:
| Title: | ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis. |
|---|---|
| Authors: | Zhao, Tiansuo1 (AUTHOR), Xiao, Di1 (AUTHOR), Jin, Fanjie1 (AUTHOR), Sun, Xugang1 (AUTHOR), Yu, Jie2 (AUTHOR), Wang, Hongwei1 (AUTHOR), Liu, Jing1 (AUTHOR), Cai, Wenrun1 (AUTHOR), Huang, Chongbiao1 (AUTHOR), Wang, Xiuchao1 (AUTHOR), Gao, Song1 (AUTHOR), Liu, Zhe3 (AUTHOR), Yang, Shengyu4 (AUTHOR), Gao, Chuntao1 (AUTHOR) gaochuntao@tjmuch.com, Hao, Jihui1 (AUTHOR) haojihui@tjmuch.com |
| Source: | British Journal of Cancer. Nov2022, Vol. 127 Issue 8, p1461-1472. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
